603387.SS
Price:
$8.34
Market Cap:
$4.23B
Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic products in China and internationally. The company provides diagnostic reagents and analyzers; calibrators; reagent raw materials, such as monoclonal and polyclonal antibodies, antigen, antiserum, and microsphere; and cardiac marker, inflammation, renal function, coagulation, thyroid function, fertility, diabetes care, and thrombus products. It also offers products in the area of cardiovascular, inflammatory, diabetes, fertility, renal, liver, and others. The company was founded in 2002 and is headquartered in Nanjing, China.
Industry
Medical - Devices
IPO Date
2017-07-17
Stock Exchange
SHH
Ticker
603387.SS
According to Getein Biotech, Inc’s latest financial reports and current stock price. The company's current PE Ratio is 20.34. This represents a change of 2.74% compared to the average of 19.80 of the last 4 quarters.
The mean historical PE Ratio of Getein Biotech, Inc over the last ten years is 21.63. The current 20.34 PE Ratio has changed 9.30% with respect to the historical average. Over the past ten years (40 quarters), 603387.SS's PE Ratio was at its highest in in the December 2022 quarter at 66.85. The PE Ratio was at its lowest in in the September 2022 quarter at 7.13.
Average
21.63
Median
19.45
Minimum
11.81
Maximum
34.84
Discovering the peaks and valleys of Getein Biotech, Inc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 65.90%
Maximum Annual PE Ratio = 34.84
Minimum Annual Increase = -66.10%
Minimum Annual PE Ratio = 11.81
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 18.75 | -6.93% |
| 2023 | 20.15 | 58.54% |
| 2022 | 12.71 | -30.33% |
| 2021 | 18.24 | -37.46% |
| 2020 | 29.16 | 65.90% |
| 2019 | 17.58 | 48.84% |
| 2018 | 11.81 | -66.10% |
| 2017 | 34.84 | 52.25% |
| 2016 | 22.88 | -24.29% |
| 2015 | 30.23 | -28.30% |
The current PE Ratio of Getein Biotech, Inc (603387.SS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
17.20
5-year avg
19.80
10-year avg
21.63
Getein Biotech, Inc’s PE Ratio is greater than Beijing Leadman Biochemistry Co.,Ltd. (-46.36), greater than Shanghai Kinetic Medical Co., Ltd (-43.87), less than Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (559.74), less than Ningbo David Medical Device Co., Ltd. (55.85), greater than Well Lead Medical Co., Ltd. (16.46), less than Zhejiang Gongdong Medical Technology Co.,Ltd. (39.68), less than Zhejiang Tailin BioEngineering Co.,Ltd (183.35), greater than Hvsen Biotechnology Co., Ltd. (19.42), less than Nanjing Vishee Medical Technology Co., Ltd (35.31), less than Cabio Biotech (Wuhan) Co., Ltd. (23.09),
| Company | PE Ratio | Market cap |
|---|---|---|
| -46.36 | $3.86B | |
| -43.87 | $3.97B | |
| 559.74 | $4.21B | |
| 55.85 | $3.72B | |
| 16.46 | $4.02B | |
| 39.68 | $4.05B | |
| 183.35 | $3.02B | |
| 19.42 | $4.18B | |
| 35.31 | $4.46B | |
| 23.09 | $3.95B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Getein Biotech, Inc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Getein Biotech, Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Getein Biotech, Inc's PE Ratio?
How is the PE Ratio calculated for Getein Biotech, Inc (603387.SS)?
What is the highest PE Ratio for Getein Biotech, Inc (603387.SS)?
What is the 3-year average PE Ratio for Getein Biotech, Inc (603387.SS)?
What is the 5-year average PE Ratio for Getein Biotech, Inc (603387.SS)?
How does the current PE Ratio for Getein Biotech, Inc (603387.SS) compare to its historical average?